PolyNovo CFO Jan Gielen to leave

• PolyNovo CFO Jan Gielen is resigning after nearly eight years to join Vitrafy Life Sciences.
• His last day is scheduled for Jan. 15, 2027, as the company begins a search for his permanent successor.
• PolyNovo has engaged an external firm to assist with appointing an interim CFO for the transition period.

PolyNovo (ASX:PNV) announced CFO Jan Gielen will step down after nearly eight years with the company to pursue a new opportunity.

Gielen joined PolyNovo in December 2018, at a time the company described as an important stage in its development.

"Jan has been part of PolyNovo through a remarkable chapter in its history. Over almost 8 years, he has helped support the company through significant growth, international expansion and increasing organisational complexity," said PolyNovo CEO Bruce Peatey.

Over the period Gielen served, the company stated it grew its annual revenue from $13.7 million in FY19 to $150.0 million in FY26.

Gielen has accepted a new position as CFO for Vitrafy Life Sciences (ASX: VFY).

Following the announcement, the PolyNovo share price was down 1.9% at $0.91.

PolyNovo also highlighted its expansion into the United States and international markets, the launch of new products from its NovoSorb platform, and its presence in more than 50 countries during this growth phase.